跳至主要内容
临床试验/NCT05933291
NCT05933291已完成不适用

Single-cell Landscape of BALF in Patients With Severe ARDS and CARDS: an Analysis of the Effectiveness of Steroid Therapy and a Comparison Between COVID-19 ARDS and ARDS From Other Etiologies

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2022年9月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
8
试验地点
1
主要终点
single-cell analysis in BALF before treatment

研究概览

简要总结

The goal of this observational study is to learn about the effect of steroid therapy in patients with COVID-19 ARDS. The main questions it aims to answer are:

  • Differences between patients with COVID-19 ARDS before and after steroid treatment in BALF single cell landscape, as well as patients with different prognosis.
  • Differences between COVID-19 and non COVID-19 ARDS patients in BALF single cell landscape.

Participants will Choose whether to use or not to utilize steroid treatment based on conditions.

详细描述

Collect BALF from COVID-19 and non-COVID-19 ARDS patients both before and during remission, then perform single-cell sequencing.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Severe ARDS patients

排除标准

  • 未提供

研究组 & 干预措施

COVID-19 with steroid

COVID-19 ARDS patients with steroid treatment

干预措施: steroid (Drug)

non-COVID-19 with steroid

non-COVID-19 ARDS patients with steroid treatment

干预措施: steroid (Drug)

结局指标

主要结局

single-cell analysis in BALF before treatment

时间窗: before treatment in ICU

collect BALF before and during treatment and perform single-cell sequencing

single-cell analysis in BALF after treatment

时间窗: After treatment in ICU for 1-4 weeks

collect BALF before and during treatment and perform single-cell sequencing

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验